U.S. market Closed. Opens in 37 seconds

UNCY | Unicycive Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
Revenue675.00K951.00KN/AN/AN/A
Cost of Revenue284.00K7.00K1.00KN/AN/A
Gross Profit391.00K944.00K-1.00KN/AN/A
Operating Expenses21.16M19.00M8.98M2.02M1.96M
Selling, General & Admin8.26M6.57M2.90M1.00M1.17M
Research & Development12.90M12.44M6.08M1.01M795.00K
Other Operating ExpensesN/AN/AN/AN/AN/A
Operating Income-20.77M-18.05M-8.98M-2.02M-1.96M
Other Expenses / Income-9.77M-6.00K-1.04M-244.00K-202.00K
Before Tax Income-30.54M-18.06M-10.02M-2.26M-2.17M
Income Tax Expenses116.11K6.00K615.00K244.00K139.00K
Net Income-30.54M-18.06M-10.63M-2.51M-2.30M
Interest Expenses82.00K6.00K628.00K244.00K139.00K
Basic Shares Outstanding24.54M15.06M15.00M15.25M15.25M
Diluted Shares Outstanding24.54M15.06M15.00M15.25M15.25M
EBITDA-20.49M-18.05M-8.98M-2.02M-1.96M
EBITDA Margin-3,035.56%-1,898.21%0.00%0.00%0.00%
EBIT-30.35M-18.05M-9.39M-2.02M-2.03M
EBIT Margin-4,495.69%-1,898.21%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙